DSS’s Impact BioMedical Receives US Patent for its Functional Fragrance Formulation Mosquito Repellant Booster | 2021-06-16 | Press Releases

ROCHESTER, N.Y., June 16, 2021 (GLOBE NEWSWIRE) — Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational firm working companies specializing in model safety expertise, blockchain safety, direct advertising and marketing, healthcare, client packaging, actual property, renewable vitality, and securitized digital belongings, as we speak introduced its wholly owned subsidiary Impact BioMedical, Inc. (“Impact BioMedical”) acquired discover of issuance (US 10,966,424) from the U.S. Patent and Trademark Office (“USPTO”) for 3FDB, a Functional Fragrance Formulation (3F) expertise that will increase the effectiveness of present mosquito repellants by means of a delightfully aromatic compound derived from botanical oils.

3FDB is an efficacy booster for present mosquito repellants comparable to DEET, Picaridin, and IR3535, amongst others. The booster incapacitates two of the three receptors that mosquitos use to search out sources of vitamin, on this case, that supply is people.
“While present mosquito repellants goal solely the gustatory receptors in bugs, 3FDB makes use of a a number of receptor strategy by focusing on ionotropic, gustatory and olfactory receptors in bugs to supply a synergistic motion to repel bugs in addition to inhibit the flexibility of bugs to detect and search prey,” says Daryl Thompson, Director of Scientific Initiatives at Impact BioMedical and founding father of superior analysis firm GRDG Sciences, LLC (“GRDG”).
While 3FDB has far-reaching purposes for on a regular basis life, a very powerful utility could possibly be saving lives. According to the National Institutes of Health, mosquitos are accountable for greater than 1,000,000 deaths every year as a result of they will host quite a lot of illnesses together with malaria, dengue, West Nile yellow fever, Zika, chikungunya, and lymphatic filariasis.
Impact BioMedical’s Chief Scientific Advisor Dr. Roscoe M. Moore, Jr., United States Assistant Surgeon General (Retired) and former Epidemic Intelligence Service (EIS) Officer at U.S. Centers for Disease Control and Prevention, mentioned, “This patent may pave the way in which for elevated safety from mosquito-borne illnesses all over the world.”
The need to save lots of lives was the impetus that led Impact BioMedical to hunt an answer to this international well being drawback. The Florida-based workforce discovered it proper in their very own yard.
How It Was Discovered
Impact BioMedical discovered its resolution to minimizing mosquito bites in orchids — particularly the elusive and legendary ghost orchid flower — discovered solely within the wild in Cuba and the Florida Everglades.
“We checked out over 300 uncommon orchids from all over the world — from Borneo to the Congo to South and Central America — in addition to our personal Florida Everglades,” mentioned Thompson. “We noticed that whereas the mosquitos had been plentiful in these environments, not one of the males had been ever drawn to or pollinating the orchids. The orchids had been principally invisible to the mosquitos.”
The workforce theorized that the orchids had been producing a chemical that inhibited the mosquitos’ skill to search out them. Through testing and analysis, the workforce recognized the chemical compounds then labored backwards to discover a solution to isolate and reproduce them.
“3FDB works in another way from conventional insect repellents. It’s efficient even at very low concentrations resulting from its multi-aspect receptor inhibition,” mentioned Thompson.
How It Works
Mosquitos have a trio of receptors — ionotropic, gustatory, and olfactory — that detect the chemical substances and carbon dioxide people expel by means of perspiration and respiration. Existing mosquito repellents focus primarily on the gustatory receptor, which diminishes the mosquito’s skill to detect people, however nonetheless leaves the opposite two receptors — ionotropic and olfactory — energetic.
3FDB, utilizing the replicated chemical compounds discovered within the ghost orchid, focuses on the opposite two receptors, and gives further safety for the third. The booster blocks the insect’s skill to detect people, primarily making people invisible to the mosquito.
“We are consistently pushing to remain forward of points affecting the world and look for methods to supply protected and significant options to fight these issues,” mentioned Mr. Chan Heng Fai, Chairman of DSS.
Long-Term Applications
The workforce relied on the experience of its companions at Chemia Corporation to make use of the chemical compounds of the orchid as the bottom for 3FDB’s deliberately mild and nice scent.
“This collaboration has confirmed the ability of analysis, and perfume is a brand new frontier in progressive expertise,” mentioned Thomas A. Meyer, Vice President, Innovation and Sustainability, Chemia Corporation.
3FDB might be included in quite a lot of purposes, comparable to sprays, lotions, laundry detergents, shampoos, soaps, material softeners, dryer sheets, misters, air flow techniques, and air fresheners.
According to Statista, the US market for mosquito repellants is forecasted to be $860 million in 2021, rising to $1.2 billion by 2025. Globally, the market is predicted to surpass $6 billion by 2027.
“We are happy with the latest difficulty of our 3F composition patent for a pure insect repellent,” mentioned Frank Heuszel, CEO of DSS and President of Impact BioMedical. “There is critical curiosity in repellents from botanical sources, and this achievement demonstrates our intent to make these distinctive merchandise out there to customers worldwide sooner or later.”
About Impact BioMedical, Inc.
Impact BioMedical, Inc. (“Impact BioMedical”) is an entirely owned subsidiary of DSS and a singular expertise supply, developer, and enterprise companion in addressing unmet wants in human healthcare and wellness. For extra data on Impact BioMedical go to http://impbio.com/ .
About Document Security Systems, Inc.
DSS is a multinational firm working companies targeted on model safety expertise, blockchain safety, direct advertising and marketing, healthcare, client packaging, actual property, renewable vitality, and securitized digital belongings. Its enterprise mannequin is predicated on a distribution sharing system by which shareholders will obtain shares in its subsidiaries as DSS strategically spins them out into IPOs. Its historic enterprise revolves round counterfeit deterrent and authentication applied sciences, good packaging, and client product engagement. DSS is led by its Chairman and largest shareholder, Mr. Fai Chan, a extremely profitable international enterprise veteran of greater than 40 years specializing in company transformation whereas managing threat. He has efficiently restructured greater than 35 companies with a mixed worth of $25 billion.
For extra data on DSS go to http://www.dsssecure.com .
Investor Contact:
Dave Gentry, CEO
RedChip Companies Inc.
407-491-4498
[email protected]
Safe Harbor Disclosure
This press launch comprises forward-looking statements which are made pursuant to the protected harbor provisions throughout the that means of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements embrace, however aren’t restricted to, statements associated to the Company’s skill to finish the financing, its meant use of proceeds and different statements that aren’t historic information. Forward-looking statements are based mostly on administration’s present expectations and are topic to dangers and uncertainties that will trigger precise outcomes or occasions to vary materially from these projected. These dangers and uncertainties, a lot of that are past our management, embrace: the danger that the general public providing of frequent inventory might not shut; dangers referring to our progress technique; our skill to acquire, carry out underneath and keep financing and strategic agreements and relationships; dangers referring to the outcomes of growth actions; our skill to draw, combine and retain key personnel; our want for substantial further funds; patent and mental property issues; competitors; in addition to different dangers described within the part entitled “Risk Factors” within the prospectus and in our different filings with the SEC, together with, with out limitation, our stories on Forms 8-Okay and 10-Q, all of which might be obtained on the SEC web site at www.sec.gov . Readers are cautioned to not place undue reliance on the forward-looking statements, which converse solely as of the date on which they’re made and mirror administration’s present estimates, projections, expectations and beliefs. We expressly disclaim any obligation or enterprise to launch publicly any updates or revisions to any forward-looking statements contained herein to mirror any change in our expectations or any modifications in occasions, circumstances or circumstances on which any such assertion is predicated, besides as required by legislation.

Recommended For You

About the Author: Jessica